Celsius Holdings Inc (CELH) experienced a notable price increase of 5.44%, reaching a 20-day high. This movement comes as the broader market shows slight gains, with the Nasdaq-100 up 0.34% and the S&P 500 up 0.06%.
The stock's rise is attributed to significant volatility observed over the past year, with a 52-week high of $66.74 and a low of $21.10. The current price at $47.55 indicates a recovery in investor confidence, potentially attracting more capital inflow. Additionally, CELH's stock price has crossed above the 200-day moving average, which is often seen as a bullish signal, suggesting that technical analysts may increase their buying interest amid this market environment.
This upward movement reflects a shift in investor sentiment, as the stock remains below its 52-week high but shows strong market participation. Investors may reassess their strategies in light of the stock's performance and the overall market conditions.
Wall Street analysts forecast CELH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CELH is 62.85 USD with a low forecast of 45.00 USD and a high forecast of 80.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
17 Analyst Rating
Wall Street analysts forecast CELH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CELH is 62.85 USD with a low forecast of 45.00 USD and a high forecast of 80.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Buy
2 Hold
1 Sell
Strong Buy
Current: 53.370
Low
45.00
Averages
62.85
High
80.00
Current: 53.370
Low
45.00
Averages
62.85
High
80.00
Piper Sandler
Overweight
maintain
$61 -> $65
2026-01-29
New
Reason
Piper Sandler
Price Target
$61 -> $65
AI Analysis
2026-01-29
New
maintain
Overweight
Reason
Piper Sandler raised the firm's price target on Celsius to $65 from $61 and keeps an Overweight rating on the shares. The firm notes Celsius looks well-positioned to beat Q4 2025 estimates. Piper believes consensus and buyside Q4 2025 sales estimates look appropriate and may have some modest upside if Alani Nu's transition was smooth, as appears likely.
JPMorgan
Overweight
maintain
$68 -> $77
2026-01-29
New
Reason
JPMorgan
Price Target
$68 -> $77
2026-01-29
New
maintain
Overweight
Reason
JPMorgan raised the firm's price target on Celsius to $77 from $68 and keeps an Overweight rating on the shares as part of a Q4 earnings preview. The firm sees a solid setup with potential upside to the company's estimates and valuation multiples. Celsius should benefit in 2026 from category captaincy under its expanded partnership with PepsiCo while Alani Nu is benefitting from ramping distribution, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CELH
Unlock Now
BNP Paribas
Outperform
maintain
$67
2026-01-16
Reason
BNP Paribas
Price Target
$67
2026-01-16
maintain
Outperform
Reason
BNP Paribas named Celsius (CELH) as a Top Pick as part of the firm's beverage group look ahead note for the year. The firm has an Outperform rating on Celsius with a $67 price target.
Needham
Gerald Pascarelli
Buy
maintain
$70
2026-01-07
Reason
Needham
Gerald Pascarelli
Price Target
$70
2026-01-07
maintain
Buy
Reason
Needham analyst Gerald Pascarelli named Celsius as its 2026 Top Pick. The firm, which has a Buy rating and $70 price target on the shares, thinks the stock is positioned to benefit from continued energy drink category strength, and with the Alani transition now largely complete, this should result in incremental distribution opportunities, which should build over the course of the year.
About CELH
Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
